Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Antibody-Drug Conjugate DFRF4539A

Known as: ADC DFRF4539A, DFRF4539A 
An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against a specific myeloma antigen and conjugated to monomethyl… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma
FcRH5 is a cell surface marker enriched on malignant plasma cells when compared to other hematologic malignancies and normal… Expand
  • table 1
  • table 2
  • figure 1
  • table 4
  • figure 2
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE